Cross Country Healthcare Inc (CCRN)

Days of sales outstanding (DSO)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Receivables turnover		5.10	5.25	4.86	4.13	4.21	4.55	3.60	3.12	3.34	4.08	4.09	3.82	4.74	4.82	5.28	4.93	4.67	4.62	5.16	4.95
DSO	days	71.51	69.53	75.13	88.42	86.69	80.26	101.44	117.04	109.30	89.44	89.21	95.65	76.98	75.69	69.07	74.09	78.13	79.04	70.75	73.68

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.10
= 71.51

Cross Country Healthcares, Inc.'s Days Sales Outstanding (DSO) has shown fluctuations over the past eight quarters. In Q4 2023, the company's DSO was 68.93 days, a slightly higher figure compared to the previous quarter's 68.33 days. This indicates that the company took approximately 68.93 days to collect its accounts receivable, a metric that improved marginally.

Looking at a broader trend, Cross Country Healthcares' DSO has generally been on a downward trajectory since Q1 2022 when it reached its peak at 116.66 days. The company has made significant progress in managing its accounts receivables more efficiently over the past few quarters. Although the DSO increased in Q1 2023 to 87.68 days, it has since shown a declining trend.

These improvements in DSO suggest that Cross Country Healthcares, Inc. has been effective in collecting payments from customers in a timely manner, which is a positive sign for the company's liquidity and cash flow management. However, it is important for the company to continue monitoring and optimizing its accounts receivable processes to maintain a healthy DSO level and ensure sustainable financial performance.